Xenetic Biosciences (XBIO) Competitor Comparison
We are evaluating the key criteria listed to compare Xenetic Biosciences (XBIO) against its competitors in the Biotechnology industry.
Market Capitalization
358 / 368Gross Profits
0 / 278Total Revenue
220 / 300EBITDA
0 / 337Free Cashflow
63 / 352Quick Ratio
90 / 357Earnings per Share
262 / 359Dividend yield
0 / 6Total Cash
323 / 358Performance 3 years
231 / 368Performance 5 years
206 / 368Performance 10 years
339 / 368Linearity 3 years
207 / 368Linearity 5 years
115 / 368Linearity 10 years
277 / 368Total Rank
368 / 368Dividend Rank
315 / 368Valuation Rank
248 / 368Piotroski Rank
322 / 368Muliplier Rank
241 / 368Performance 5 years - XBIO ranking 206 / 368
Obligatory risk notice
We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.